CSNV.F Stock Overview
Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
Corbion N.V. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €19.69 |
52 Week High | €27.35 |
52 Week Low | €16.85 |
Beta | 0.94 |
1 Month Change | -7.69% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -63.30% |
5 Year Change | -35.83% |
Change since IPO | -7.34% |
Recent News & Updates
Recent updates
Shareholder Returns
CSNV.F | US Chemicals | US Market | |
---|---|---|---|
7D | -7.7% | -2.9% | -3.7% |
1Y | n/a | 5.6% | 20.2% |
Return vs Industry: Insufficient data to determine how CSNV.F performed against the US Chemicals industry.
Return vs Market: Insufficient data to determine how CSNV.F performed against the US Market.
Price Volatility
CSNV.F volatility | |
---|---|
CSNV.F Average Weekly Movement | n/a |
Chemicals Industry Average Movement | 5.5% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CSNV.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CSNV.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1919 | 2,669 | Olivier Rigaud | www.corbion.com |
Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors.
Corbion N.V. Fundamentals Summary
CSNV.F fundamental statistics | |
---|---|
Market cap | US$1.18b |
Earnings (TTM) | US$77.59m |
Revenue (TTM) | US$1.54b |
15.2x
P/E Ratio0.8x
P/S RatioIs CSNV.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CSNV.F income statement (TTM) | |
---|---|
Revenue | €1.44b |
Cost of Revenue | €1.11b |
Gross Profit | €331.50m |
Other Expenses | €258.60m |
Earnings | €72.90m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 08, 2024
Earnings per share (EPS) | 1.23 |
Gross Margin | 22.96% |
Net Profit Margin | 5.05% |
Debt/Equity Ratio | 113.3% |
How did CSNV.F perform over the long term?
See historical performance and comparison